SCHEMBL20780641

SCHEMBL20780641

Cc1ccc(CN[C@@H]2CCN3CCC[C@H]3C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.51
BACE1 P56817 3/20 0.51
BCHE P06276 2/20 0.49
FABP6 P51161 1/20 0.43
ALDH1A1 P00352 1/20 0.41
PLA2G1B P04054 1/20 0.41
ALPL P05186 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
OPRK1 P41145 1/20 0.41
HRH3 Q9Y5N1 3/20 0.40
RB1 P06400 3/20 0.39
TSHR P16473 1/20 0.39
HPGD P15428 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TACR1 P25103 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20780642 1.00 ACHE (0.51) ACHEBACE1BCHEFABP6ALDH1A1
SCHEMBL4206550 0.87 ACHE (0.58) ACHEBACE1BCHEFABP6HRH3
SCHEMBL20765890 0.86 BCHE (0.51) ACHEBACE1BCHEFABP6HRH3
SCHEMBL20765867 0.86 BCHE (0.51) ACHEBACE1BCHEFABP6HRH3
SCHEMBL20766139 0.86 BCHE (0.51) ACHEBACE1BCHEFABP6HRH3
SCHEMBL20766105 0.86 BCHE (0.51) ACHEBACE1BCHEFABP6HRH3
SCHEMBL20766194 0.86 BCHE (0.51) ACHEBACE1BCHEFABP6HRH3
SCHEMBL20794833 0.83 ACHE (0.48) ACHEBACE1BCHEALDH1A1OPRK1
SCHEMBL20794834 0.83 ACHE (0.48) ACHEBACE1BCHEALDH1A1OPRK1
SCHEMBL23686826 0.82 BCHE (0.50) ACHEBACE1BCHEHRH3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040104-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed